Yvonne Bouter

Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer’s disease

The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease

The glymphatic pathway in neurological disorders

Sphingolipids and their metabolism in physiology and disease

Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse

Understanding the functions and relationships of the glymphatic system and meningeal lymphatics

Oxidative stress and the amyloid beta peptide in Alzheimer’s disease

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Implications of GABAergic Neurotransmission in Alzheimer’s Disease

A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease

The role of short-chain fatty acids in microbiota–gut–brain communication

Design of amyloidogenic peptide traps

A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease

Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?

Inflammation as a central mechanism in Alzheimer's disease

Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents

Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain

N-truncated amyloid β (Aβ) 4-42 forms stable aggregates and induces acute and long-lasting behavioral deficits

Abundance of Aβ5-xlike immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer’s disease

Deciphering the Molecular Profile of Plaques, Memory Decline and Neuron Loss in Two Mouse Models for Alzheimer’s Disease by Deep Sequencing

Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X

Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncated Abeta in sporadic Alzheimer disease cases and mouse models

Endothelial LRP1 transports amyloid-β1–42 across the blood-brain barrier